Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients (original) (raw)
Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation
Janel Boyle
Pharmaceutics
View PDFchevron_right
Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning
Janel Boyle
Translational Research, 2016
View PDFchevron_right
Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer
Peter Steinherz
Cancer Chemotherapy and Pharmacology, 2011
View PDFchevron_right
Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes
M. Bierings
Blood Advances, 2019
View PDFchevron_right
Determination of intracellular fludarabine triphosphate in human peripheral blood mononuclear cells by LC–MS/MS
Janel Boyle
Journal of Pharmaceutical and Biomedical Analysis, 2013
View PDFchevron_right
A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial
Claire Dearden
Cancer, 2010
View PDFchevron_right
Outcomes of Substituting Oral Fludarabine for Intravenous Fludarabine in Combination with Cytarabine and Filgrastim for Treatment of Primary Refractory or Relapsed Acute Leukemias
Roberta Demichelis-gómez
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 2015
View PDFchevron_right
Fludarabine in chronic leukaemia
Alan Astrow
The Lancet, 1996
View PDFchevron_right
Fludarabine Allows Dose Reduction for Total Body Irradiation in Pediatric Hematopoietic Stem Cell Transplantation
Shiao Woo
International Journal of Radiation Oncology*Biology*Physics, 2007
View PDFchevron_right
Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomes
Leslie Shaw
Bone Marrow Transplantation, 2010
View PDFchevron_right
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration
Giuseppe G M Leone, Dimitar Efremov
Annals of Hematology, 2008
View PDFchevron_right
Simultaneous determination of fludarabine and clofarabine in human plasma by LC-MS/MS
Janel Boyle
Journal of Chromatography B, 2014
View PDFchevron_right
Pharmacokinetic targeting of iv BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve …
leonard perez
Bone Marrow …, 2010
View PDFchevron_right
Fludarabine and Exposure-Targeted Busulfan Compares Favorably with Busulfan/Cyclophosphamide-Based Regimens in Pediatric Hematopoietic Cell Transplantation: Maintaining Efficacy with Less Toxicity
birgitta versluys
Biology of Blood and Marrow Transplantation, 2014
View PDFchevron_right
Determination of fludarabine in a pharmaceutical formulation by LC
Antonino Villari
Journal of Pharmaceutical and Biomedical Analysis, 1999
View PDFchevron_right
Impact of dose intensity on outcome of fludarabine, cyclophosphamide, and rituximab regimen given in the first-line therapy for chronic lymphocytic leukemia
B. Cazin
Haematologica, 2013
View PDFchevron_right
The effect of G-CSF on the in vitro cytotoxicity of cytarabine and fludarabine in the FLAG combination in pediatric acute myeloid leukemia
Eric Haarman
International Journal of Oncology, 2004
View PDFchevron_right
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen
Julio Delgado
Cytotherapy, 2009
View PDFchevron_right
In vitro susceptibility of CD4+ and CD8+ T cell subsets to fludarabine
Paula Fernández Calotti
Biochemical Pharmacology, 2003
View PDFchevron_right
Fludarabine and cytosine-arabinoside for poor-risk acute myeloid leukemia
Anna Candoni
…, 1998
View PDFchevron_right
Population pharmacokinetics and optimal design of paediatric studies for famciclovir
Kayode Ogungbenro
British Journal of Clinical Pharmacology, 2009
View PDFchevron_right
Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias
Mary Rios
Clinical cancer research : an official journal of the American Association for Cancer Research, 2003
View PDFchevron_right
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome
Pat Chiusolo
Annals of Hematology, 2010
View PDFchevron_right
Fludarabine phosphate for the treatment of low grade lymphoid malignancy
Owen Smith
British Journal of Cancer, 1991
View PDFchevron_right
Modeling the 5-Fluorouracil Area Under the Curve Versus Dose Relationship to Develop a Pharmacokinetic Dosing Algorithm for Colorectal Cancer Patients Receiving FOLFOX6
Abebe Haregewoin
The Oncologist, 2012
View PDFchevron_right
Use of clofarabine for acute childhood leukemia
Andrea Pession
Biologics: Targets & Therapy, 2010
View PDFchevron_right
Effect of Fludarabine on Leukocyte Functions
ayça doğan
Chemotherapy, 2004
View PDFchevron_right
Phase II evaluation of fludarabine phosphate in patients with central nervous system tumors
Jerry Guy
Investigational New Drugs, 1991
View PDFchevron_right
Exposure-Response Analysis of Alvocidib (Flavopiridol) Treatment by Bolus or Hybrid Administration in Newly Diagnosed or Relapsed/Refractory Acute Leukemia Patients
Judith Karp
Clinical cancer research : an official journal of the American Association for Cancer Research, 2017
View PDFchevron_right
Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics
Andrew McLachlan
Frontiers in Pharmacology
View PDFchevron_right